line_item,period,value,symbol
Tax Effect Of Unusual Items,2025-03-31 00:00:00,10590000.0,ACLGATI.NS
Tax Rate For Calcs,2025-03-31 00:00:00,0.3,ACLGATI.NS
Normalized EBITDA,2025-03-31 00:00:00,969700000.0,ACLGATI.NS
Total Unusual Items,2025-03-31 00:00:00,35300000.0,ACLGATI.NS
Total Unusual Items Excluding Goodwill,2025-03-31 00:00:00,35300000.0,ACLGATI.NS
Net Income From Continuing Operation Net Minority Interest,2025-03-31 00:00:00,117600000.0,ACLGATI.NS
Reconciled Depreciation,2025-03-31 00:00:00,734900000.0,ACLGATI.NS
Reconciled Cost Of Revenue,2025-03-31 00:00:00,2439700000.0,ACLGATI.NS
EBITDA,2025-03-31 00:00:00,1005000000.0,ACLGATI.NS
EBIT,2025-03-31 00:00:00,270100000.0,ACLGATI.NS
Net Interest Income,2025-03-31 00:00:00,17600000.0,ACLGATI.NS
Interest Expense,2025-03-31 00:00:00,231300000.0,ACLGATI.NS
Interest Income,2025-03-31 00:00:00,248900000.0,ACLGATI.NS
Normalized Income,2025-03-31 00:00:00,92890000.0,ACLGATI.NS
Net Income From Continuing And Discontinued Operation,2025-03-31 00:00:00,133400000.0,ACLGATI.NS
Total Expenses,2025-03-31 00:00:00,15169900000.0,ACLGATI.NS
Rent Expense Supplemental,2025-03-31 00:00:00,,ACLGATI.NS
Diluted Average Shares,2025-03-31 00:00:00,,ACLGATI.NS
Basic Average Shares,2025-03-31 00:00:00,,ACLGATI.NS
Diluted EPS,2025-03-31 00:00:00,,ACLGATI.NS
Basic EPS,2025-03-31 00:00:00,,ACLGATI.NS
Diluted NI Availto Com Stockholders,2025-03-31 00:00:00,133400000.0,ACLGATI.NS
Net Income Common Stockholders,2025-03-31 00:00:00,133400000.0,ACLGATI.NS
Otherunder Preferred Stock Dividend,2025-03-31 00:00:00,0.0,ACLGATI.NS
Net Income,2025-03-31 00:00:00,133400000.0,ACLGATI.NS
Minority Interests,2025-03-31 00:00:00,13900000.0,ACLGATI.NS
Net Income Including Noncontrolling Interests,2025-03-31 00:00:00,119500000.0,ACLGATI.NS
Net Income Discontinuous Operations,2025-03-31 00:00:00,15800000.0,ACLGATI.NS
Net Income Continuous Operations,2025-03-31 00:00:00,103700000.0,ACLGATI.NS
Tax Provision,2025-03-31 00:00:00,-64900000.0,ACLGATI.NS
Pretax Income,2025-03-31 00:00:00,38800000.0,ACLGATI.NS
Other Non Operating Income Expenses,2025-03-31 00:00:00,56400000.0,ACLGATI.NS
Special Income Charges,2025-03-31 00:00:00,35300000.0,ACLGATI.NS
Other Special Charges,2025-03-31 00:00:00,-55900000.0,ACLGATI.NS
Write Off,2025-03-31 00:00:00,,ACLGATI.NS
Impairment Of Capital Assets,2025-03-31 00:00:00,20600000.0,ACLGATI.NS
Restructuring And Mergern Acquisition,2025-03-31 00:00:00,,ACLGATI.NS
Net Non Operating Interest Income Expense,2025-03-31 00:00:00,17600000.0,ACLGATI.NS
Total Other Finance Cost,2025-03-31 00:00:00,,ACLGATI.NS
Interest Expense Non Operating,2025-03-31 00:00:00,231300000.0,ACLGATI.NS
Interest Income Non Operating,2025-03-31 00:00:00,248900000.0,ACLGATI.NS
Operating Income,2025-03-31 00:00:00,-70500000.0,ACLGATI.NS
Operating Expense,2025-03-31 00:00:00,12730200000.0,ACLGATI.NS
Other Operating Expenses,2025-03-31 00:00:00,12730200000.0,ACLGATI.NS
Research And Development,2025-03-31 00:00:00,,ACLGATI.NS
Selling General And Administration,2025-03-31 00:00:00,,ACLGATI.NS
Selling And Marketing Expense,2025-03-31 00:00:00,,ACLGATI.NS
General And Administrative Expense,2025-03-31 00:00:00,,ACLGATI.NS
Gross Profit,2025-03-31 00:00:00,12659700000.0,ACLGATI.NS
Cost Of Revenue,2025-03-31 00:00:00,2439700000.0,ACLGATI.NS
Total Revenue,2025-03-31 00:00:00,15099400000.0,ACLGATI.NS
Operating Revenue,2025-03-31 00:00:00,15099400000.0,ACLGATI.NS
Tax Effect Of Unusual Items,2024-03-31 00:00:00,105780000.0,ACLGATI.NS
Tax Rate For Calcs,2024-03-31 00:00:00,0.3,ACLGATI.NS
Normalized EBITDA,2024-03-31 00:00:00,602100000.0,ACLGATI.NS
Total Unusual Items,2024-03-31 00:00:00,352600000.0,ACLGATI.NS
Total Unusual Items Excluding Goodwill,2024-03-31 00:00:00,352600000.0,ACLGATI.NS
Net Income From Continuing Operation Net Minority Interest,2024-03-31 00:00:00,121000000.0,ACLGATI.NS
Reconciled Depreciation,2024-03-31 00:00:00,689400000.0,ACLGATI.NS
Reconciled Cost Of Revenue,2024-03-31 00:00:00,2452900000.0,ACLGATI.NS
EBITDA,2024-03-31 00:00:00,954700000.0,ACLGATI.NS
EBIT,2024-03-31 00:00:00,265300000.0,ACLGATI.NS
Net Interest Income,2024-03-31 00:00:00,-227400000.0,ACLGATI.NS
Interest Expense,2024-03-31 00:00:00,300200000.0,ACLGATI.NS
Interest Income,2024-03-31 00:00:00,72800000.0,ACLGATI.NS
Normalized Income,2024-03-31 00:00:00,-125820000.0,ACLGATI.NS
Net Income From Continuing And Discontinued Operation,2024-03-31 00:00:00,145300000.0,ACLGATI.NS
Total Expenses,2024-03-31 00:00:00,14982600000.0,ACLGATI.NS
Rent Expense Supplemental,2024-03-31 00:00:00,282100000.0,ACLGATI.NS
Diluted Average Shares,2024-03-31 00:00:00,129732143.0,ACLGATI.NS
Basic Average Shares,2024-03-31 00:00:00,129732143.0,ACLGATI.NS
Diluted EPS,2024-03-31 00:00:00,1.12,ACLGATI.NS
Basic EPS,2024-03-31 00:00:00,1.12,ACLGATI.NS
Diluted NI Availto Com Stockholders,2024-03-31 00:00:00,145300000.0,ACLGATI.NS
Net Income Common Stockholders,2024-03-31 00:00:00,145300000.0,ACLGATI.NS
Otherunder Preferred Stock Dividend,2024-03-31 00:00:00,0.0,ACLGATI.NS
Net Income,2024-03-31 00:00:00,145300000.0,ACLGATI.NS
Minority Interests,2024-03-31 00:00:00,84100000.0,ACLGATI.NS
Net Income Including Noncontrolling Interests,2024-03-31 00:00:00,61200000.0,ACLGATI.NS
Net Income Discontinuous Operations,2024-03-31 00:00:00,24300000.0,ACLGATI.NS
Net Income Continuous Operations,2024-03-31 00:00:00,36900000.0,ACLGATI.NS
Tax Provision,2024-03-31 00:00:00,-71800000.0,ACLGATI.NS
Pretax Income,2024-03-31 00:00:00,-34900000.0,ACLGATI.NS
Other Non Operating Income Expenses,2024-03-31 00:00:00,34200000.0,ACLGATI.NS
Special Income Charges,2024-03-31 00:00:00,352600000.0,ACLGATI.NS
Other Special Charges,2024-03-31 00:00:00,-350300000.0,ACLGATI.NS
Write Off,2024-03-31 00:00:00,201000000.0,ACLGATI.NS
Impairment Of Capital Assets,2024-03-31 00:00:00,-2300000.0,ACLGATI.NS
Restructuring And Mergern Acquisition,2024-03-31 00:00:00,,ACLGATI.NS
Net Non Operating Interest Income Expense,2024-03-31 00:00:00,-227400000.0,ACLGATI.NS
Total Other Finance Cost,2024-03-31 00:00:00,,ACLGATI.NS
Interest Expense Non Operating,2024-03-31 00:00:00,300200000.0,ACLGATI.NS
Interest Income Non Operating,2024-03-31 00:00:00,72800000.0,ACLGATI.NS
Operating Income,2024-03-31 00:00:00,-194200000.0,ACLGATI.NS
Operating Expense,2024-03-31 00:00:00,12529700000.0,ACLGATI.NS
Other Operating Expenses,2024-03-31 00:00:00,12529700000.0,ACLGATI.NS
Research And Development,2024-03-31 00:00:00,,ACLGATI.NS
Selling General And Administration,2024-03-31 00:00:00,235400000.0,ACLGATI.NS
Selling And Marketing Expense,2024-03-31 00:00:00,36500000.0,ACLGATI.NS
General And Administrative Expense,2024-03-31 00:00:00,198900000.0,ACLGATI.NS
Gross Profit,2024-03-31 00:00:00,12335500000.0,ACLGATI.NS
Cost Of Revenue,2024-03-31 00:00:00,2452900000.0,ACLGATI.NS
Total Revenue,2024-03-31 00:00:00,14788400000.0,ACLGATI.NS
Operating Revenue,2024-03-31 00:00:00,14788400000.0,ACLGATI.NS
Tax Effect Of Unusual Items,2023-03-31 00:00:00,-32550000.0,ACLGATI.NS
Tax Rate For Calcs,2023-03-31 00:00:00,0.3,ACLGATI.NS
Normalized EBITDA,2023-03-31 00:00:00,1046700000.0,ACLGATI.NS
Total Unusual Items,2023-03-31 00:00:00,-108500000.0,ACLGATI.NS
Total Unusual Items Excluding Goodwill,2023-03-31 00:00:00,-108500000.0,ACLGATI.NS
Net Income From Continuing Operation Net Minority Interest,2023-03-31 00:00:00,-92800000.0,ACLGATI.NS
Reconciled Depreciation,2023-03-31 00:00:00,592100000.0,ACLGATI.NS
Reconciled Cost Of Revenue,2023-03-31 00:00:00,15848000000.0,ACLGATI.NS
EBITDA,2023-03-31 00:00:00,938200000.0,ACLGATI.NS
EBIT,2023-03-31 00:00:00,346100000.0,ACLGATI.NS
Net Interest Income,2023-03-31 00:00:00,-246400000.0,ACLGATI.NS
Interest Expense,2023-03-31 00:00:00,293100000.0,ACLGATI.NS
Interest Income,2023-03-31 00:00:00,47200000.0,ACLGATI.NS
Normalized Income,2023-03-31 00:00:00,-16850000.0,ACLGATI.NS
Net Income From Continuing And Discontinued Operation,2023-03-31 00:00:00,-92800000.0,ACLGATI.NS
Total Expenses,2023-03-31 00:00:00,16942700000.0,ACLGATI.NS
Rent Expense Supplemental,2023-03-31 00:00:00,316400000.0,ACLGATI.NS
Diluted Average Shares,2023-03-31 00:00:00,125441055.0,ACLGATI.NS
Basic Average Shares,2023-03-31 00:00:00,125441055.0,ACLGATI.NS
Diluted EPS,2023-03-31 00:00:00,-0.74,ACLGATI.NS
Basic EPS,2023-03-31 00:00:00,-0.74,ACLGATI.NS
Diluted NI Availto Com Stockholders,2023-03-31 00:00:00,-92800000.0,ACLGATI.NS
Net Income Common Stockholders,2023-03-31 00:00:00,-92800000.0,ACLGATI.NS
Otherunder Preferred Stock Dividend,2023-03-31 00:00:00,0.0,ACLGATI.NS
Net Income,2023-03-31 00:00:00,-92800000.0,ACLGATI.NS
Minority Interests,2023-03-31 00:00:00,16300000.0,ACLGATI.NS
Net Income Including Noncontrolling Interests,2023-03-31 00:00:00,-109100000.0,ACLGATI.NS
Net Income Discontinuous Operations,2023-03-31 00:00:00,,ACLGATI.NS
Net Income Continuous Operations,2023-03-31 00:00:00,-109100000.0,ACLGATI.NS
Tax Provision,2023-03-31 00:00:00,162100000.0,ACLGATI.NS
Pretax Income,2023-03-31 00:00:00,53000000.0,ACLGATI.NS
Other Non Operating Income Expenses,2023-03-31 00:00:00,176400000.0,ACLGATI.NS
Special Income Charges,2023-03-31 00:00:00,-109300000.0,ACLGATI.NS
Other Special Charges,2023-03-31 00:00:00,4900000.0,ACLGATI.NS
Write Off,2023-03-31 00:00:00,69900000.0,ACLGATI.NS
Impairment Of Capital Assets,2023-03-31 00:00:00,34500000.0,ACLGATI.NS
Restructuring And Mergern Acquisition,2023-03-31 00:00:00,0.0,ACLGATI.NS
Net Non Operating Interest Income Expense,2023-03-31 00:00:00,-246400000.0,ACLGATI.NS
Total Other Finance Cost,2023-03-31 00:00:00,500000.0,ACLGATI.NS
Interest Expense Non Operating,2023-03-31 00:00:00,293100000.0,ACLGATI.NS
Interest Income Non Operating,2023-03-31 00:00:00,47200000.0,ACLGATI.NS
Operating Income,2023-03-31 00:00:00,231700000.0,ACLGATI.NS
Operating Expense,2023-03-31 00:00:00,1094700000.0,ACLGATI.NS
Other Operating Expenses,2023-03-31 00:00:00,722100000.0,ACLGATI.NS
Research And Development,2023-03-31 00:00:00,0.0,ACLGATI.NS
Selling General And Administration,2023-03-31 00:00:00,219900000.0,ACLGATI.NS
Selling And Marketing Expense,2023-03-31 00:00:00,43500000.0,ACLGATI.NS
General And Administrative Expense,2023-03-31 00:00:00,176400000.0,ACLGATI.NS
Gross Profit,2023-03-31 00:00:00,1326400000.0,ACLGATI.NS
Cost Of Revenue,2023-03-31 00:00:00,15848000000.0,ACLGATI.NS
Total Revenue,2023-03-31 00:00:00,17174400000.0,ACLGATI.NS
Operating Revenue,2023-03-31 00:00:00,17174400000.0,ACLGATI.NS
Tax Effect Of Unusual Items,2022-03-31 00:00:00,13920000.0,ACLGATI.NS
Tax Rate For Calcs,2022-03-31 00:00:00,0.3,ACLGATI.NS
Normalized EBITDA,2022-03-31 00:00:00,569000000.0,ACLGATI.NS
Total Unusual Items,2022-03-31 00:00:00,46400000.0,ACLGATI.NS
Total Unusual Items Excluding Goodwill,2022-03-31 00:00:00,46400000.0,ACLGATI.NS
Net Income From Continuing Operation Net Minority Interest,2022-03-31 00:00:00,88700000.0,ACLGATI.NS
Reconciled Depreciation,2022-03-31 00:00:00,349200000.0,ACLGATI.NS
Reconciled Cost Of Revenue,2022-03-31 00:00:00,13722700000.0,ACLGATI.NS
EBITDA,2022-03-31 00:00:00,615400000.0,ACLGATI.NS
EBIT,2022-03-31 00:00:00,266200000.0,ACLGATI.NS
Net Interest Income,2022-03-31 00:00:00,-242400000.0,ACLGATI.NS
Interest Expense,2022-03-31 00:00:00,271200000.0,ACLGATI.NS
Interest Income,2022-03-31 00:00:00,31500000.0,ACLGATI.NS
Normalized Income,2022-03-31 00:00:00,56220000.0,ACLGATI.NS
Net Income From Continuing And Discontinued Operation,2022-03-31 00:00:00,88700000.0,ACLGATI.NS
Total Expenses,2022-03-31 00:00:00,14775900000.0,ACLGATI.NS
Rent Expense Supplemental,2022-03-31 00:00:00,420800000.0,ACLGATI.NS
Diluted Average Shares,2022-03-31 00:00:00,125529164.0,ACLGATI.NS
Basic Average Shares,2022-03-31 00:00:00,122753182.0,ACLGATI.NS
Diluted EPS,2022-03-31 00:00:00,0.71,ACLGATI.NS
Basic EPS,2022-03-31 00:00:00,0.72,ACLGATI.NS
Diluted NI Availto Com Stockholders,2022-03-31 00:00:00,88700000.0,ACLGATI.NS
Net Income Common Stockholders,2022-03-31 00:00:00,88700000.0,ACLGATI.NS
Otherunder Preferred Stock Dividend,2022-03-31 00:00:00,0.0,ACLGATI.NS
Net Income,2022-03-31 00:00:00,88700000.0,ACLGATI.NS
Minority Interests,2022-03-31 00:00:00,133000000.0,ACLGATI.NS
Net Income Including Noncontrolling Interests,2022-03-31 00:00:00,-44300000.0,ACLGATI.NS
Net Income Discontinuous Operations,2022-03-31 00:00:00,,ACLGATI.NS
Net Income Continuous Operations,2022-03-31 00:00:00,-44300000.0,ACLGATI.NS
Tax Provision,2022-03-31 00:00:00,39300000.0,ACLGATI.NS
Pretax Income,2022-03-31 00:00:00,-5000000.0,ACLGATI.NS
Other Non Operating Income Expenses,2022-03-31 00:00:00,119300000.0,ACLGATI.NS
Special Income Charges,2022-03-31 00:00:00,44400000.0,ACLGATI.NS
Other Special Charges,2022-03-31 00:00:00,-374300000.0,ACLGATI.NS
Write Off,2022-03-31 00:00:00,146500000.0,ACLGATI.NS
Impairment Of Capital Assets,2022-03-31 00:00:00,52900000.0,ACLGATI.NS
Restructuring And Mergern Acquisition,2022-03-31 00:00:00,130500000.0,ACLGATI.NS
Net Non Operating Interest Income Expense,2022-03-31 00:00:00,-242400000.0,ACLGATI.NS
Total Other Finance Cost,2022-03-31 00:00:00,2700000.0,ACLGATI.NS
Interest Expense Non Operating,2022-03-31 00:00:00,271200000.0,ACLGATI.NS
Interest Income Non Operating,2022-03-31 00:00:00,31500000.0,ACLGATI.NS
Operating Income,2022-03-31 00:00:00,71500000.0,ACLGATI.NS
Operating Expense,2022-03-31 00:00:00,1053200000.0,ACLGATI.NS
Other Operating Expenses,2022-03-31 00:00:00,909400000.0,ACLGATI.NS
Research And Development,2022-03-31 00:00:00,130500000.0,ACLGATI.NS
Selling General And Administration,2022-03-31 00:00:00,194600000.0,ACLGATI.NS
Selling And Marketing Expense,2022-03-31 00:00:00,13500000.0,ACLGATI.NS
General And Administrative Expense,2022-03-31 00:00:00,181100000.0,ACLGATI.NS
Gross Profit,2022-03-31 00:00:00,1124700000.0,ACLGATI.NS
Cost Of Revenue,2022-03-31 00:00:00,13722700000.0,ACLGATI.NS
Total Revenue,2022-03-31 00:00:00,14847400000.0,ACLGATI.NS
Operating Revenue,2022-03-31 00:00:00,14847400000.0,ACLGATI.NS
Tax Effect Of Unusual Items,2021-03-31 00:00:00,,ACLGATI.NS
Tax Rate For Calcs,2021-03-31 00:00:00,,ACLGATI.NS
Normalized EBITDA,2021-03-31 00:00:00,,ACLGATI.NS
Total Unusual Items,2021-03-31 00:00:00,,ACLGATI.NS
Total Unusual Items Excluding Goodwill,2021-03-31 00:00:00,,ACLGATI.NS
Net Income From Continuing Operation Net Minority Interest,2021-03-31 00:00:00,,ACLGATI.NS
Reconciled Depreciation,2021-03-31 00:00:00,,ACLGATI.NS
Reconciled Cost Of Revenue,2021-03-31 00:00:00,,ACLGATI.NS
EBITDA,2021-03-31 00:00:00,,ACLGATI.NS
EBIT,2021-03-31 00:00:00,,ACLGATI.NS
Net Interest Income,2021-03-31 00:00:00,,ACLGATI.NS
Interest Expense,2021-03-31 00:00:00,,ACLGATI.NS
Interest Income,2021-03-31 00:00:00,,ACLGATI.NS
Normalized Income,2021-03-31 00:00:00,,ACLGATI.NS
Net Income From Continuing And Discontinued Operation,2021-03-31 00:00:00,,ACLGATI.NS
Total Expenses,2021-03-31 00:00:00,,ACLGATI.NS
Rent Expense Supplemental,2021-03-31 00:00:00,479500000.0,ACLGATI.NS
Diluted Average Shares,2021-03-31 00:00:00,121945977.0,ACLGATI.NS
Basic Average Shares,2021-03-31 00:00:00,121945977.0,ACLGATI.NS
Diluted EPS,2021-03-31 00:00:00,-18.69,ACLGATI.NS
Basic EPS,2021-03-31 00:00:00,-18.69,ACLGATI.NS
Diluted NI Availto Com Stockholders,2021-03-31 00:00:00,,ACLGATI.NS
Net Income Common Stockholders,2021-03-31 00:00:00,,ACLGATI.NS
Otherunder Preferred Stock Dividend,2021-03-31 00:00:00,,ACLGATI.NS
Net Income,2021-03-31 00:00:00,,ACLGATI.NS
Minority Interests,2021-03-31 00:00:00,,ACLGATI.NS
Net Income Including Noncontrolling Interests,2021-03-31 00:00:00,,ACLGATI.NS
Net Income Discontinuous Operations,2021-03-31 00:00:00,,ACLGATI.NS
Net Income Continuous Operations,2021-03-31 00:00:00,,ACLGATI.NS
Tax Provision,2021-03-31 00:00:00,,ACLGATI.NS
Pretax Income,2021-03-31 00:00:00,,ACLGATI.NS
Other Non Operating Income Expenses,2021-03-31 00:00:00,,ACLGATI.NS
Special Income Charges,2021-03-31 00:00:00,,ACLGATI.NS
Other Special Charges,2021-03-31 00:00:00,,ACLGATI.NS
Write Off,2021-03-31 00:00:00,39300000.0,ACLGATI.NS
Impairment Of Capital Assets,2021-03-31 00:00:00,,ACLGATI.NS
Restructuring And Mergern Acquisition,2021-03-31 00:00:00,0.0,ACLGATI.NS
Net Non Operating Interest Income Expense,2021-03-31 00:00:00,,ACLGATI.NS
Total Other Finance Cost,2021-03-31 00:00:00,7000000.0,ACLGATI.NS
Interest Expense Non Operating,2021-03-31 00:00:00,,ACLGATI.NS
Interest Income Non Operating,2021-03-31 00:00:00,,ACLGATI.NS
Operating Income,2021-03-31 00:00:00,,ACLGATI.NS
Operating Expense,2021-03-31 00:00:00,,ACLGATI.NS
Other Operating Expenses,2021-03-31 00:00:00,,ACLGATI.NS
Research And Development,2021-03-31 00:00:00,,ACLGATI.NS
Selling General And Administration,2021-03-31 00:00:00,158300000.0,ACLGATI.NS
Selling And Marketing Expense,2021-03-31 00:00:00,7600000.0,ACLGATI.NS
General And Administrative Expense,2021-03-31 00:00:00,150700000.0,ACLGATI.NS
Gross Profit,2021-03-31 00:00:00,,ACLGATI.NS
Cost Of Revenue,2021-03-31 00:00:00,,ACLGATI.NS
Total Revenue,2021-03-31 00:00:00,,ACLGATI.NS
Operating Revenue,2021-03-31 00:00:00,,ACLGATI.NS
